Company profile: Amprius Technologies
1.1 - Company Overview
Company description
- Provider of high energy density lithium-ion batteries leveraging silicon nanowire anode technology originally developed at Stanford, delivering up to 500 Wh/kg and 1300 Wh/L. Offerings include SiMaxx and SiCore platforms for high-performance and electric mobility, a 500 Wh/kg battery platform, and a planned gigawatt-hour scale factory in Colorado for mass production.
Products and services
- Gigawatt-Hour Scale Factory: Gigawatt-hour-scale facility in Colorado enabling mass production of SiMaxx and SiCore lithium-ion batteries, significantly increasing manufacturing capacity for silicon anode products
- SiMaxxTM: Custom-engineered silicon anode lithium-ion battery delivering up to 500 Wh/kg and 1300 Wh/L energy densities for high-performance applications
- SiCoreTM: High-temperature-rated silicon anode battery platform with a unique structure that improves cycle life and stability at elevated temperatures, architected for electric mobility applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Amprius Technologies
NaturalNano
HQ: United States
Website
- Description: Provider of proprietary nanomaterials technologies and products, developing unique processes for refining naturally occurring nanotubes and other nanomaterials to add competitive properties to a range of applications; near-term goal to make commercial quantities of high-quality naturally occurring nanotubes, along with licenses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NaturalNano company profile →
PDS Biotech
HQ: United States
Website
- Description: Provider of the Versamune® T cell activating platform that stimulates immune responses to cancer-specific proteins, and a pipeline of subcutaneous investigational immunotherapies: Versamune® HPV (Phase 2), PDS0102 (TARP), PDS0103 (MUC1), PDS0104 (TRP2-positive melanoma), and PDS01ADC, an IL-12 fused antibody-drug conjugate enhancing T cell activity, in preclinical and clinical programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PDS Biotech company profile →
Capres
HQ: Australia
Website
- Description: Provider of micro- and nano-scale electrical metrology products and instruments, including M4PP and M12PP microscopic probes, microRSP-A300, microRSP-M300, microRSP-M200, microHALL-A300, microHALL-M300, and CIPTech-M300 and CIPTech-M200.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capres company profile →
NanoGram Devices
HQ: United States
Website
- Description: Provider of nanotechnology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoGram Devices company profile →
Silence Therapeutics
HQ: United Kingdom
Website
- Description: Provider of RNA technology and a proprietary genetic medicine platform leveraging RNA interference to target and silence disease-associated genes without altering DNA. Developing siRNA therapies including zerlasiran (SLN360) to reduce high lipoprotein(a) and divesiran (SLN124) targeting TMPRSS6 to manage iron levels and treat polycythemia vera by increasing hepcidin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silence Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Amprius Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Amprius Technologies
2.2 - Growth funds investing in similar companies to Amprius Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Amprius Technologies
4.2 - Public trading comparable groups for Amprius Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →